YB-1 Expression Is Associated with Lymph Node Metastasis and Drug Resistance to Adriamycin in Breast Cancer

Table 1

Clinical and pathological characteristics of the patients.

	Number	value
Number of patients	48
Gender
Female	48
Median age (range) (years)	46 (27-70)
Age (years)		0.057
≤35	11 (22.9%)
35-49	20 (41.6%)
50-70	17 (35.4%)
Tumor size (diameter, cm)
<5 cm	28 (58.3%)	0.314
≥5 cm	20 (41.7%)
Histological grade ( (%))		0.234
Grade 2	21 (43.8%)
Grade 3	27 (56.2%)
Lymph node status ( (%))		0.017
Negative	21 (43.8%)
Positive	27 (56.2%)
Subtype ( (%))		0.320
Luminal A	6 (12.5%)
Luminal B	21 (43.8%)
Triple negative	10 (20.8%)
HR-, Her2+	11 (22.9%)
Pathological stage at diagnosis ( (%))		0.229
Stage II	28 (58.3%)
Stage III	20 (41.7%)